Related Experiment Video
Updated: Jan 30, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
[CLINICAL AND EPIDEMIOLOGICAL ASSESSMENT OF THE EFFECTIVENESS OF VAC- CINATION OF CHILDREN AGAINST PNEUMOCOCCAL
Insights
Anti-pneumococcal vaccination significantly reduced childhood illness rates, including pneumonia, by over 13% in flood-affected Amur Region areas. This vaccination program demonstrated high medical and socio-economic efficiency.
Area of Science:
- Pediatrics
- Epidemiology
- Public Health
Background:
- Flooding in the Amur Region created conditions conducive to infectious disease outbreaks.
- Children, particularly those with risk factors, are vulnerable to pneumococcal infections.
Purpose of the Study:
- To assess the effectiveness of anti-pneumococcal vaccination as part of anti-epidemic measures in flood-affected areas.
- To evaluate the impact of pneumococcal conjugate vaccine (Prevenar-13) on childhood illnesses.
Main Methods:
- A monitoring program involved 4988 children aged 2-5 years with risk factors for pneumococcal infection.
- Vaccination utilized Prevenar-13; data on acute respiratory infections, otitis media, pneumonia, and meningitis were collected post-vaccination.
- Effectiveness was measured using indicators like the prophylactic vaccination coefficient and infection index.
Main Results:
- Total childhood morbidity decreased by 13.6% post-vaccination.
- Pneumonia incidence dropped 2.3-fold, with a 14.6% reduction in total illness duration.
- Antibiotic therapy courses decreased by 21.3%, hospital admissions by 38.4%, and parental temporary disability by 11.1%.
Conclusions:
- The anti-pneumococcal vaccination program demonstrated high medical and socio-economic efficiency in the Amur Region.
- Implementation of clinical and epidemiological monitoring alongside vaccination is effective for preventing community-acquired pneumonia.
Aim:
To study the effectiveness of anti-pneumococcal vaccination of children in the organiza- tion of anti-epidemic measures in the areas of the flood in the Amur region.
Material And Methods:
The monitoring program included 4988 children aged 2 to 5 years who have risk factors for pneu- mococcal infection. Pneumococcal conjugate vaccine Prevenar- 13 was used for immunization. Data on the incidence of child with acute respiratory infection, acute otitis media, pneumonia, meningitis during the post-vaccination period were taken into account. To evaluate the effective- ness of vaccination we used indicators and specific criteria (coefficient prophylactic vaccination and infection index).
Results:
The level of total morbidity of children in post-immunization pe- riod decreased by 13.6%; the number of cases ofpneumonia in the population of observed children decreased by 2.3 times; the total duration of the illness in children decreased by 14.6%, the number of.courses of antibiotic therapy was reduced by 21.3%, the number of hospital admissions of children - 38.4%, the number of days of temporary disability ofparents - 11.1%. Direct dependence of the degree of effectiveness of vaccination against pneumococcal disease by the age of children is determined.
Conclusion:
The findings suggest that implementation of the program of clinical and epidemiological monitoring and prevention of community-acquired pneumonia with use of a vaccine against pneumococcal infections in the territory of the Amur Region has a high level of medical and socio-economic efficiency.
Related Concept Videos
Vaccinations
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Endocarditis II: Clinical Features of Infective Endocarditis
Introduction to Epidemiology
Causality in Epidemiology
Angina III: Clinical Manifestations and Assessment

